The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma
- 1 April 2000
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (4) , 606-611
- https://doi.org/10.1016/s0190-9622(00)90172-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- PET in oncology: Will it replace the other modalities?Seminars in Nuclear Medicine, 1997
- Cost-effectiveness of PET imaging in clinical oncologyNuclear Medicine and Biology, 1996
- Positron emission tomography in the detection and management of metastatic melanomaMelanoma Research, 1996
- Whole-Body Positron Emission Tomography: An Accurate Staging Modality for Metastatic MelanomaArchives of Dermatology, 1996
- Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanomaArchives of Dermatology, 1995
- The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Minimal-Access Surgery for Staging of Malignant MelanomaArchives of Surgery, 1995
- Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucoseBritish Journal of Dermatology, 1995
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Evaluation of Staging Workup in Malignant MelanomaArchives of Surgery, 1989